Product Information
ANTI-NAUSEA LIQUID is a generic product labeled by Rugby Laboratories, priced at $0.0235 per ML under NDC 00536130297. Its NADAC has been published 276 times since Jun 23, 2021.
Strength
1.87; 1.87; 21.5 g/5mL; g/5mL; mg/5mL
Manufacturer
Rugby LaboratoriesNDC
00536130297
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACIDApproval Type
Unapproved
On Market Since
9/9/2020
Price Statistics
The NADAC for ANTI-NAUSEA LIQUID has been published 276 times since Jun 23, 2021, and over the history we have for it it has risen 30.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0235 per ML |
|---|---|
| All-time high | $0.0267 (Mar 13, 2024) |
| All-time low | $0.0159 (Nov 23, 2022) |
| 52-week high | $0.0239 |
| 52-week low | $0.0218 |
| Median price | $0.0218 |
| Average price | $0.0217 |
| Largest weekly change | +34.2% (Dec 21, 2022) |
| Weeks tracked | 276 |
| Tracking since | Jun 23, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rugby Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dextrose(glucose),Levulose(fructose),Phosphoric acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ANTI-NAUSEA LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for ANTI-NAUSEA LIQUID, manufactured by Rugby Laboratories, is $0.0235 per ML (NDC 00536130297), effective Sep 30, 2026.
How has the price of ANTI-NAUSEA LIQUID changed over time?
Over the history we have for it, the NADAC for ANTI-NAUSEA LIQUID has risen 30.8%. It has been tracked across 276 weekly CMS publications since Jun 23, 2021.
What are the highest and lowest recorded NADAC prices for ANTI-NAUSEA LIQUID?
Since Jun 23, 2021, the NADAC for ANTI-NAUSEA LIQUID has ranged from a low of $0.0159 (Nov 23, 2022) to a high of $0.0267 (Mar 13, 2024), with a median of $0.0218 per ML.
Are there cheaper alternatives to ANTI-NAUSEA LIQUID?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ANTI-NAUSEA LIQUID in a comparable dosage form, but none are currently priced below it.
Who manufactures ANTI-NAUSEA LIQUID?
ANTI-NAUSEA LIQUID (NDC 00536130297) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.